New patent for Rigel Pharms drug TAVALISSE

Annual Drug Patent Expirations for TAVALISSE Tavalisse is a drug marketed by Rigel Pharms Inc and is included in one NDA. It is available from one supplier. There are fourteen…

The post New patent for Rigel Pharms drug TAVALISSE appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog